Literature DB >> 24947354

Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes.

Aldina Reis1, Catarina Mateus2, Pedro Melo3, João Figueira1, José Cunha-Vaz1, Miguel Castelo-Branco4.   

Abstract

It is unknown whether independent neural damage may occur in the pre-/absent vascular diabetic retinopathy (DR). To exclude vasculopathy, it is important to measure the integrity of the blood-retinal barrier (BRB). This cross-sectional study addressed this problem in type 1 diabetic patients with normal ocular fundus and absent breakdown of the BRB (confirmed with vitreous fluorometry). These were compared with a group with disrupted BRB (with normal fundus or initial DR) and normal controls. Multifocal electroretinography and chromatic/achromatic contrast sensitivity were measured in these 42 patients with preserved visual acuity. Amplitudes of neurophysiological responses (multifocal electroretinogram) were decreased in all eccentricity rings in both clinical groups, when compared with controls, with sensitivity >78% for a specificity level of 90%. Implicit time changes were also found in the absence of initial DR. Impaired contrast sensitivity along chromatic axes was also observed, and achromatic thresholds were also different between controls and both clinical groups. The pattern of changes in the group without baseline BRB permeability alterations, as probed by psychophysical and electrophysiological measurements, does thereby confirm independent damage mechanisms. We conclude that retinal neuronal changes can be diagnosed in type 1 diabetes, independently of the breakdown of the BRB and onset of vasculopathy.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Year:  2014        PMID: 24947354     DOI: 10.2337/db13-1673

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

Review 1.  Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.

Authors:  C Hernández; A Simó-Servat; P Bogdanov; R Simó
Journal:  J Endocrinol Invest       Date:  2017-03-29       Impact factor: 4.256

Review 2.  The role of Toll-like receptors in retinal ischemic diseases.

Authors:  Wen-Qin Xu; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

3.  Diabetic brain or retina? Visual psychophysical performance in diabetic patients in relation to GABA levels in occipital cortex.

Authors:  Mafalda Sanches; Sulaiman I Abuhaiba; Otília C d'Almeida; Bruno Quendera; Leonor Gomes; Carolina Moreno; Daniela Guelho; Miguel Castelo-Branco
Journal:  Metab Brain Dis       Date:  2017-03-30       Impact factor: 3.584

4.  Relations between Cardiac and Visual Phenotypes in Diabetes: A Multivariate Approach.

Authors:  Bárbara Oliveiros; Mafalda Sanches; Bruno Quendera; Bruno Graça; Daniela Guelho; Leonor Gomes; Francisco Carrilho; Filipe Caseiro-Alves; Miguel Castelo-Branco
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

5.  Can ocular changes be detected early in children and adolescents with type 1 diabetes mellitus without retinopathy by using optical biometry and optical coherence tomography?

Authors:  Hakan Öztürk; Bediz Özen; Hayrullah Manyas; Gönül Çatlı; Bumin Dündar
Journal:  Int Ophthalmol       Date:  2020-06-01       Impact factor: 2.031

Review 6.  The innate immune system in diabetic retinopathy.

Authors:  Warren W Pan; Feng Lin; Patrice E Fort
Journal:  Prog Retin Eye Res       Date:  2021-01-08       Impact factor: 19.704

Review 7.  Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2020-11-12       Impact factor: 19.704

Review 8.  Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases.

Authors:  Maria H Madeira; Raquel Boia; Paulo F Santos; António F Ambrósio; Ana R Santiago
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

Review 9.  Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?

Authors:  Priyia Pusparajah; Learn-Han Lee; Khalid Abdul Kadir
Journal:  Front Physiol       Date:  2016-06-01       Impact factor: 4.566

Review 10.  Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.

Authors:  Cristina Hernández; Massimo Dal Monte; Rafael Simó; Giovanni Casini
Journal:  J Diabetes Res       Date:  2016-03-31       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.